Coeptis Therapeutics (COEP) Institutional Ownership → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free COEP Stock Alerts $0.33 +0.01 (+3.98%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Coeptis Therapeutics (NASDAQ:COEP)CurrentInstitutional OwnershipPercentage13.88%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$2.16MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$138.04K Get COEP Insider Trade Alerts Want to know when executives and insiders are buying or selling Coeptis Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data COEP Institutional Buying and Selling by Quarter Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. Coeptis Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024Armistice Capital LLC3,520,000$2.76M0.0%+59.1%10.320% 11/15/2023Armistice Capital LLC2,212,000$2.57M0.0%-5.1%8.799% 8/15/2023Ionic Capital Management LLC45,000$70K0.0%N/A0.209% 7/21/2023Creative Planning645,103$1M0.0%N/A2.995% 5/12/2023Antara Capital LP45,000$64K0.0%N/A0.220% 2/14/2023Susquehanna International Group LLP16,341$25K0.0%N/A0.319% 2/10/2023Creative Planning645,103$988K0.0%N/A12.600% 2/10/2023HRT Financial LP172,635$267K0.0%N/A3.372% 2/8/2023 Cambridge Investment Research Advisors Inc.31,670$48K0.0%N/A0.619% 2/6/2023West Chester Capital Advisors Inc.2,863,382$4.39M8.7%N/A55.925% (Data available from 1/1/2016 forward) COEP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of COEP shares? During the previous two years, the following institutional investors and hedge funds held shares of Coeptis Therapeutics shares: West Chester Capital Advisors Inc. ($4.39M), Armistice Capital LLC ($2.76M), Creative Planning ($1M), HRT Financial LP ($267K), Ionic Capital Management LLC ($70K), Antara Capital LP ($64K), and Cambridge Investment Research Advisors Inc. ($48K).Learn more on COEP's institutional investors. What percentage of Coeptis Therapeutics stock is owned by institutional investors? 13.88% of Coeptis Therapeutics stock is owned by institutional investors. Learn more on COEP's institutional investor holdings. Which institutional investors have been buying Coeptis Therapeutics stock? The following institutional investors have purchased Coeptis Therapeutics stock in the last 24 months: West Chester Capital Advisors Inc. ($2.86M), Armistice Capital LLC ($1.31M), Creative Planning ($1.29M), HRT Financial LP ($172.64K), Ionic Capital Management LLC ($45K), Antara Capital LP ($45K), and Cambridge Investment Research Advisors Inc. ($31.67K). How much institutional buying is happening at Coeptis Therapeutics? Institutional investors have bought a total of 5,772,234 shares in the last 24 months. This purchase volume represents approximately $7.87M in transactions. Which Coeptis Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Coeptis Therapeutics stock in the last 24 months: Armistice Capital LLC ($119K). How much institutional selling is happening at Coeptis Therapeutics? Institutional investors have sold a total of 119,000 shares in the last 24 months. This volume of shares sold represents approximately $138.04K in transactions. Related Companies: Senti Biosciences Major Shareholders Inhibikase Therapeutics Major Shareholders BioCardia Major Shareholders Genetic Technologies Major Shareholders Creative Medical Technology Major Shareholders PharmaCyte Biotech Major Shareholders BM Technologies Major Shareholders Aptose Biosciences Major Shareholders Finch Therapeutics Group Major Shareholders Evaxion Biotech A/S Major Shareholders This page (NASDAQ:COEP) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coeptis Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
